Funding

Veritas Aortic Solutions raises $12M for aortic disease treatment advance

Veritas Aortic Solutions has raised $12m to advance its technology for the treatment of aortic root and ascending aorta pathologies. Veritas’ seed financing round was...

Cerenion secures over €4.3M to accelerate European expansion

Cerenion’s investment round, organized together with Springvest, was successfully completed, attracting total investments of EUR 4.359 million. The funding will support Cerenion’s next phase of...

RaysightMed secures nearly $15M Series D to advance precision cardiac diagnosis

RaysightMed officially announced the successful completion of its nearly RMB 100 million Series D financing round. This round was jointly facilitated by state-owned capital...

ThIA Santé Mentale raises €5M to scale AviPsy

In Montpellier, the startup ThIA has developed AviPsy, a digital platform designed to streamline access to mental health care. The company, which claims to...

Oli raises $6.5M to predict birth complications before they happen

Australian medtech startup Oli has raised $6.5 million in a Series A3 funding round to accelerate the development of its maternal and fetal monitoring...

Vortex Imaging secures $12M for 3D imaging expansion

Vortex Imaging has raised a $12 million financing round to speed clinical development, approval and commercial launch of its cloud-enabled computational ultrasound platform. This...

Neurosoft Bioelectronics closes $7.5M seed funding round to support BCI

Neurosoft Bioelectronics announced that it secured $7.5 million in an oversubscribed seed funding round. Geneva, Switzerland-based Neurosoft, which has its U.S. operations in New York,...

Cagent Vascular closes $41M Series D, reports first-in-human IVL cases

Cagent Vascular announced the first-in-human cases with its Serranator Sonic IVL system alongside significant funding. In addition to the first human use of the intravascular...

Boston Scientific invests $1.5B in MiRus, enters $2B share repurchase agreement

Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake...
123...129Page 2 of 129

Latest articles